Compare Globus Medical Inc. Class A Common Stock (GMED) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs CarMax, Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while CarMax, Inc trades at $51.31 (market cap $7.07B). The key difference: Globus Medical Inc. Class A Common Stock is the larger of the two by market cap, and CarMax, Inc is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and CarMax, Inc for 49 Days on average.
| GMED | KMX | |
|---|---|---|
Market Cap | $10.25B | $7.07B |
Volume | 1,059,528 | 2,330,911.51 |
Sector | Health | Consumer Cyclical |
52-Week High | $96.82 | $64.22 |
52-Week Low | $58.33 | $30.88 |
Typical Hold Time | 0 Days | 49 Days |
Enterprise Value | $9.76B | $24.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
CarMax (KMX) trades at $50.81, showing modest daily gains of 0.24% amid bearish technical signals. The company delivered strong Q2 2027 results with EPS of $1.16 beating estimates by 58%, driven by 19.5% revenue growth to $7.9 billion. Despite positive earnings momentum, the stock faces headwinds with bearish moving averages and oscillators indicating technical weakness. Recent leadership appointments and strategic updates signal management's focus on growth initiatives.
KMX presents a mixed outlook with strong fundamental performance offset by technical bearishness. The 29% upside to consensus price target of $60.63 offers potential reward, but investors face risks from declining profit margins, high debt levels, and competitive pressures in the used car market. Recent earnings beat and strategic initiatives provide catalysts, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
